By Wayne Koberstein, Executive Editor, Life Science Leader magazine
Follow Me On Twitter @WayneKoberstein
The stories of longtime leaders, still active in the industry, sharing their historical perspectives on life sciences industry innovation.
To transform: to start with a scientific hypothesis, use it to create or isolate a potentially therapeutic substance, devise and conduct bench tests, move the compound into preclinical, then clinical trials, and with a great measure of luck, finally gain approval to take the drug to market and make it available to patients. Some people disdain the drug-commercialization process as fraught with fraud and conflict of interest. Others celebrate it as … pure magic. In the latter camp would be Deborah Dunsire, who has lived and worked in a world driven by commercial drug development for three decades.